Literature DB >> 6895379

Deficiency of protein C in congenital thrombotic disease.

J H Griffin, B Evatt, T S Zimmerman, A J Kleiss, C Wideman.   

Abstract

A family with a history of recurring thrombosis was studied to determine if a plasma protein deficiency could account for the observed disease. Protein C levels in plasma were determined immunologically using the Laurell rocket technique. The propositus, his father, and his paternal uncle, who are severely affected, had 38-49% of normal levels of protein C antigen, whereas unaffected family members had normal levels. There was no familial deficiency of antithrombin III and plasminogen. Because activated protein C is a potent in vitro anticoagulant enzyme and an in vivo profibrinolytic agent, it is suggested that the recurrent thrombotic disease in this family is due to an inherited deficiency in protein C.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6895379      PMCID: PMC370934          DOI: 10.1172/jci110385

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.

Authors:  O EGEBERG
Journal:  Thromb Diath Haemorrh       Date:  1965-06-15

2.  A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization.

Authors:  J Stenflo
Journal:  J Biol Chem       Date:  1976-01-25       Impact factor: 5.157

3.  A new vitamin K-dependent protein. A phospholipid-binding zymogen of a serine esterase.

Authors:  C T Esmon; J Stenflo; J W Suttie
Journal:  J Biol Chem       Date:  1976-05-25       Impact factor: 5.157

4.  Electroimmuno assay.

Authors:  C B Laurell
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

5.  Familial thrombosis due to antithrombin 3 deficiency.

Authors:  E Marciniak; C H Farley; P A DeSimone
Journal:  Blood       Date:  1974-02       Impact factor: 22.113

6.  A new inherited coagulation disorder caused by an abnormal fibrinogen ('fibrinogen Baltimore').

Authors:  E A Beck; P Charache; D P Jackson
Journal:  Nature       Date:  1965-10-09       Impact factor: 49.962

7.  Anticoagulant properties of bovine plasma protein C following activation by thrombin.

Authors:  W Kisiel; W M Canfield; L H Ericsson; E W Davie
Journal:  Biochemistry       Date:  1977-12-27       Impact factor: 3.162

8.  Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis.

Authors:  N Aoki; M Moroi; Y Sakata; N Yoshida; M Matsuda
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

9.  Fibrinogen ""New York"--an abnormal fibrinogen associated with thromboembolism: functional evaluation.

Authors:  H Al-Mondhiry; S B Bilezikian; H L Nossel
Journal:  Blood       Date:  1975-05       Impact factor: 22.113

10.  Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.

Authors:  A R Thompson
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

View more
  159 in total

Review 1.  Diagnosis and management of inherited and acquired thrombophilias.

Authors:  F A Spencer; R C Becker
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

2.  The Laboratory of Hypercoagulability: A Review of Present-Day Techniques.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-07       Impact factor: 2.300

3.  Chemical synthesis and spontaneous folding of a multidomain protein: anticoagulant microprotein S.

Authors:  T M Hackeng; J A Fernández; P E Dawson; S B Kent; J H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

4.  Unique distance- and DNA-turn-dependent interactions in the human protein C gene promoter confer submaximal transcriptional activity.

Authors:  C A Spek; R M Bertina; P H Reitsma
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

5.  Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.

Authors:  Weihong Tang; Saonli Basu; Xiaoxiao Kong; James S Pankow; Nena Aleksic; Adrian Tan; Mary Cushman; Eric Boerwinkle; Aaron R Folsom
Journal:  Blood       Date:  2010-08-27       Impact factor: 22.113

6.  Protein C receptor stimulates multiple signaling pathways in breast cancer cells.

Authors:  Daisong Wang; Chunye Liu; Jingqiang Wang; Yingying Jia; Xin Hu; Hai Jiang; Zhi-Ming Shao; Yi Arial Zeng
Journal:  J Biol Chem       Date:  2017-12-07       Impact factor: 5.157

7.  Heterozygous protein C deficiency type I.

Authors:  B Kemkes-Matthes
Journal:  Blut       Date:  1989-04

8.  Proteolytic maturation of protein C upon engineering the mouse mammary gland to express furin.

Authors:  R Drews; R K Paleyanda; T K Lee; R R Chang; A Rehemtulla; R J Kaufman; W N Drohan; H Luboń
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

9.  Risk factors for thrombosis in lupus patients.

Authors:  P Hasselaar; R H Derksen; L Blokzijl; M Hessing; H K Nieuwenhuis; B N Bouma; P G De Groot
Journal:  Ann Rheum Dis       Date:  1989-11       Impact factor: 19.103

10.  Fibrinogen Irvine: a qualitatively abnormal fibrinogen associated with the predisposition to recurrent visceral and peripheral venous thrombosis.

Authors:  R R Lehmer; A N Elias; M J Capdeville; D R Brown; H E Branson
Journal:  J Natl Med Assoc       Date:  1985-07       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.